The caspase-3-dependent production of PGE2 has also been reported to support the stimulation of tumour re-growth in mice following therapy-induced apoptosis in models of breast cancer, melanoma, bladder carcinoma and glioblastoma [4,6,16,84]. The gene discussed is CASP3; the disease is glioblastoma.